Summary A novel trophoblast cell surface antigen has been defined by a monoclonal antibody 5T4, raised following immunisation with wheat germ agglutinin (WGA) purified glycoproteins from deoxycholate (DOC) solubilised human syncytiotrophoblast plasma membrane (StMPM). The distribution of the antigen was determined by indirect immunoperoxidase staining of sections of normal organ and placental tissues as well as immunofluorescence and radiobinding assays with a wide variety of cell lines representing differing normal and tumour cell types. In frozen sections of normal full term placenta, 5T4 is strongly expressed only by the syncytiotrophoblast, some extravillous cytotrophoblast and the amniotic epithelium. The 5T4 antigen is apparently not expressed by any maternal component of the placenta nor is it detected in adult liver, lung, bronchus, heart, testis, ovary, brain, or muscle. The antigen is apparently expressed by several specialised epithelia. Immunoprecipitation of radiolabelled StMPM indicated that 5T4 molecules are glycoproteins of mol. wt of -72 kD on SDS-PAGE. 5T4 antigen is selectively expressed by diverse tumour cell lines, including those of developmental origin. The molecular characteristics, relatively restricted normal tissue distribution and expression by certain tumour cell types make this antigen worthy of future study for use as a diagnostic marker of malignancy.
Trophoblast demonstrates some functional properties of neoplastic tissue, viz. invasiveness of host tissue and escape from immunological surveillance. Several monoclonal antibodies to trophoblast membrane proteins have been described. In terms of cancer research, the rationale behind this approach has been to identify 'oncofoetal' antigens present on both trophoblast and neoplastic cells (Johnson, 1984) . If such antigens were restricted to neoplastic tissues, then these reagents would be potentially useful in diagnosis, tumour localisation and drug targeting. Of those monoclonal antibodies that do identify trophoblast oncofoetal antigens, relatively few have been fully characterised. A variety of monoclonal antibodies have been shown to be reactive with the placental alkaline phosphatase (PLAP), and these have shown the greatest clinical potential (McLaughlin, 1986) . The low level of PLAP in normal non-pregnant sera, and restricted tissue distribution has been useful in monitoring some ovarian carcinomas by a serum assay (McDicken et al., 1985) and radio-imaging (Epenetos et al., 1985; Critchley et al., 1986) . However, PLAP-reactive monoclonal antibodies are not reactive with all ovarian carcinomas. Clearly there is a place for further reagents against different molecular species which show a different and/or wider tumour cell type reactivity. Here we describe a novel trophoblast antigen which is also expressed by some tumour cell lines.
Materials and methods
Purification of syncytiotrophoblast glycoproteins StMPM was purified from full term human placentae, obtained within I h post partum, by the method of Smith et al. (1974) . The StMPM pellet was solubilised in 0.5% DOC in tris-buffered saline (TBS, 0.15 M NaCl, 25mM tris, pH 8.0) containing 0.1 mM phenylsulphonylmethyl fluoride (PMSF) and centrifuged at 14,000g for 10min. The WGA-reactive glycoproteins were then purified by incubation of the supernatant with WGA-Sepharose (5mg ligand ml-1 Sepharose) for 1 h at room temperature. The beads were washed extensively in TBS/0.5% DOC, and the specifically bound glycoproteins eluted in 5ml of 0.2M N-acetyl glucosamine (Sigma) in TBS. The eluted fraction was extensively dialysed against 30 mM ammonium bicarbonate (pH 7.9), and lyophilised.
Generation of monoclonal antibody A male BALB/c mouse was immunised by 6 i.p. injections of WGA-purified StMPM glycoproteins (100-200,rg/injection).
Spleen cells were fused with NS 1 murine myeloma cells (Kohler & Milstein, 1975) , and the cells plated out in 24 well Linbro plates at 7 x 105 cells/well. After 2 weeks, wells were assayed for StMPM reactive antibody by immunodotting. Positive clones were picked directly and further subcloned by limiting dilution. The antibody subclass was determined by double radial diffusion using a monoclonal isotype typing kit (Serotec, Bicester, UK).
Cell culture Details of the cell lines are given in Table III Stern et al., 1984 Stern et al., ,1986 . Tritiated sodium borohydride labelling of cell surface glycoproteins was carried out as described by Axelsson et al. (1978) . Autoradiography and fluorography were as described in Thompson et al. (1984) using pre-flashed Fuji X-ray film.
Immunoperoxidase and immunofluorescence labelling Immunoperoxidase staining of frozen tissue sections was carried out by the method of Bulmer & Sunderland (1983) . Tissues were obtained as soon as possible post-mortem, always within 12 h, and processed immediately. Indirect immunofluoresecence with cell suspensions was as described previously . A monoclonal antibody generated in this laboratory against a widely expressed human antigen (mAb 1D2) was used as positive control. Preparation of crude membrane from normal human tissues Tissues were obtained within 12 h of death, and processed immediately. Tissue (10-20 g) was finely chopped, rinsed, and homogenised in 10-20 ml of ice-cold PBS containing 5 mM MgCl2 and 0.1 mM PMSF with 20 strokes of a Dounce homogeniser. The homogenate was centrifuged at 10,000g for 20 min, the pellet discarded and the supernatant centrifuged at 100,000g for 1 h. This pellet was solubilised in 0.5% (w/v) DOC/TBS containing 0.1 mM PMSF and unsolubilised material pelleted by centrifugation at 14,000g. The protein concentration of the supernatant was determined by the method of Lowry et al. (1951) . Membranes from 12h old placentae were prepared identically and acted as positive controls.
Gel filtration StMPM protein (50mg) was solubilised in 6.5ml of 1.0% (w/v) DOC/TBS containing 0.1 mM PMSF, centrifuged at 100,000g for 30 min, and the supernatant fractionated over S200 Sephacryl (Pharmacia). Column size was 90 x 2 cm, running buffer was 0. 1% (w/v) NaDOC/TBS containing 0.1 mM PMSF. Flow rate was 17 ml h-1. Fraction size was 3.3 ml. The column was calibrated with the following proteins; Equine ferritin (Sigma), IgG (Kabi), transferrin (Sigma), Bovine serum albumin (Sigma) and ovalbumin (Sigma). Fractions were assayed for 5T4 antigen in ELISA and immunodot.
ELISA and immunodot ELISA plates (Dynatech) were activated by 1 h incubation with 100 p1/well of PBS containing 0.25% gluteraldehyde (BDH) , the plates washed with PBS, and 100I1/well of undiluted or 10-fold diluted fractions from gel filtration bound to the plates by overnight incubation at 4°C. Following washing, the plates were incubated with 1% BSA/TBS as blocking agent. ELISA was then carried out as described (Johnson et al., 1981) . Immunodotting on nitrocellulose was carried out using the Bio-Rad Dot-Blot apparatus. Fractions from gel filtration were loaded at 10 pl and 100 pl/dot. NaDOC solubilised plasma membrane was loaded in the range of 50 pg-12.5 ng protein/dot. The following antigens were loaded at 1 g protein/dot; transferrin (Sigma), PLAP (gift of Dr P.J. McLaughlin), human placental lactogen (HPL) (Sigma), calmodulin (Sigma), IgG (Miles Ltd.) , albumin (Miles Ltd.) and normal human sera. The nitrocellulose sheet was blocked with 3% (w/v) BSA (Sigma) in TBS and processed as described previously (Webb et al., 1985) . In both ELISA and immunodot, mAb 1D2 was used as positive control.
Enzymatic digestion StMPM membranes (-1 mg protein) were treated overnight at 37°C with either 2mg trypsin (Boehringer), 2mg pronase (Boehringer), 0.1 U neuraminidase (Behringwerke) in 300 p1 PBS or 10Uml-1 N-glycanase (Genzyme) in buffer containing final concentrations as follows: 0.17% SDS; 0.2 M tris-HCl, pH8.7; 10mM 1,10-phenanthroline hydrate (in methanol); 1.25% NP-40 (Plummer et al., 1984) . The treated membranes were solubilised in DOC/TBS and 5T4 residual antigenicity assayed by dot-blot. 5T4 immunoprecipitates of detergent solubilised '25I-radiolabelled StMPM were eluted from protein-A-Sepharose with 0.5% SDS in water and incubated overnight at 37°C with or without 10Uml-Nglycanase in buffer as above. Digests were subjected to reduced SDS-PAGE and autoradiography.
Results
The monoclonal antibody 5T4 is a murine IgGl. All work detailed in this study was carried out using subclone 5T4.B8. The preliminary screen by immunodot showed that the antigen recognised was none of the following major proteins associated with the trophoblast; IgG, transferrin, PLAP, HPL, albumin, calmodulin, nor was it detectable in serum.
Tissue distribution 5T4 antigen expression in first trimester and full term placentae was investigated using indirect immunoperoxidase staining of frozen sections. Figure 1 illustrates antigen expression in term villous placenta as assessed by immunohistology of frozen sections. Villous trophoblast was strongly labelled by mAb 5T4, whereas the stroma was negative. There was specific labelling of the amniotic epithelium and extravillous cytotrophoblast of the chorion laeve but not of the amniotic mesenchyme or maternal decidua (Figure lc 5T4 shows specific labelling of villous trophoblast and extravillous cytotrophoblast of the chorion laeve as well as amniotic epithelium. Positive control mAb lD2 labels all cell types; mAb H316 labels trophoblast of the chorion laeve and amniotic epithelium. Normal mouse serum shows no labelling.
of non-pregnant uterus and endocervical glands showed some specific labelling with mAb 5T4. Some small vessels in various tissues appeared to be weakly stained. (Table II) .
Expression by cell lines 5T4 antigen expression by cell lines of normal and neoplastic mol. wt of 120 kD, although there was a small peak of reactivity in the void volume (Figure 4 ).
Antigenicity
Isolated StMPM membranes were digested-with trypsin, pronase, neuraminidase or N-glycanase, the components solubilised and subjected to immunodot assay. Both proteases and N-glycanase destroyed 5T4 antigenicity, whilst neuraminidase did not (Table IV) . The effects of various fixatives on 5T4 antigenicity as expressed by Tera-2 cells was assessed by solid-phase radiobinding assay. Neither Bouins' fixative, buffered formalin, gluteraldehyde nor absolute ethanol were found to significantly affect 5T4 binding index relative to PBS control (data not shown).
Discussion
5T4 antigen has a relatively limited tissue distribution. It appears to be a pan-trophoblast marker which is expressed by all types of trophoblast examined as early as 9 weeks of development. It is specific for this tissue type within the placenta except for the amniotic epithelium which is also antigen positive. On the basis of immunoperoxidase staining of frozen sections from normal tissue, 5T4 antigen is also expressed by certain epithelial cell types. It should be noted that several 'trophoblast-characteristic' antigens, such as PLAP, are in fact found in normal tissues at trace concentrations (McLaughlin, 1986) . Using a solid phase immunoassay to quantitate the expression of 5T4 relative to normal tissue, 5T4 antigen was found in placental plasma membrane in at least a 1,000-fold higher concentration than that found in other normal tissues tested. However, this level of sensitivity would not necessarily detect expression in minor subpopulations of cells within a given tissue.
Several antibodies have exhibited a similar pattern of reactivity with normal epithelial tissues, for example HMFG1 and 2 (Taylor-Papadimitriou et al., 1981; Wilkinson et al., 1984) , and CA 1, 2 and 3 (Bramwell et al., 1985) , but this has not limited their use in immunoscintigraphy (Pateisky et al., 1985) or diagnosis of neoplasia (Warr & Cruickshank, 1987) . In this respect, 5T4 is reactive with tumour cell lines of a diverse, but select origin, including those of a developmental nature, such as choriocarcinoma and embryonal carcinoma. The reason for 5T4 antigen expression by cell lines of such apparent diversity of tissue is not clear; the normal cell line types tested are all of embryonic origin. The lack of reactivity with tumour cell lines derived from lung, bronchus and lymphoid tissue is (McLaughlin et al., 1982) . In the study by Rettig et al. (1985) , a series of six monoclonal antibodies were generated against choriocarcinoma cells, one of which was reactive with neoplastic, but not normal, kidney cells; the other mAbs did not demonstrate such a selective expression.
Several trophoblast associated antigens have been reported in the literature to be expressed on tumour cell lines. 5T4 antigen does, however, appear to be novel. On the basis of reactivity in dot-blots and other criteria, we have specifically excluded PLAP and transferrin as the 5T4 antigen. On the basis of mol. wt in reduced gels, we have further excluded transferrin receptor (Trowbridge et al., 1984) , insulin receptor (Ullrich et al., 1985) , EGF receptor (Waterfield et al., 1982) , HMFGI and 2 (Burchell et al., 1983) , CA (Wiseman et al., 1984) , CEA (Krantz et al., 1979) , alpha foeto-protein (Ruoslahti, 1979) Fraction No. Figure 4 Gel filtration of 5T4 antigenic molecules. Solubilised StMPM protein fractionated over S200 Sephacryl in the presence of detergent. Fractionated 5T4 antigenicity assessed in ELISA family of mucin type glycoproteins (Swallow et al., 1987) , but with clear differences from those defined by the CA or HMFG series of antigens (Wiseman et al., 1984; Burchell et al., 1983) . These latter glycoproteins are defined by several monoclonal antibodies which have been shown to be reactive with a wide range of malignant tumour cells but also reactive with certain specialised normal epithelia.
The limited tissue distribution and expression by selected tumour cell lines encourages further studies on the expression of 5T4 antigen by solid tumours of diverse origin. Analysis of primary tumour material from a variety of neoplasms has revealed specific staining of some different tumours (Southall, Boxer, Bagshawe et al., in preparation). The 5T4 antigenicity appears to depend on both protein and carbohydrate structures but studies using a radiobinding assay with a teratocarcinoma cell line suggested that fixation procedures do not destroy 5T4 antigenicity. Thus immunohistological analysis of 5T4 may be possible using fixed and embedded material. 
